Nifty 50 closed at 23,161.6, down 0.2% on the day, still below its 200-day average and 12% off its 52-week high. The overall regime remains weak but recovering — now into its eighth consecutive day of that read — with the near-term bias neutral-to-up. Breadth was narrow: decliners led advancers 1,685 to 537, new lows outnumbered new highs 152 to 78, and only 30.8% of stocks sit above their 200-day average. The constructive signal underneath is that the Stage-2 advancing cohort has continued to widen — up 3.8 over five days, 10.5 over twenty, and 13.4 over sixty — and 20 golden crosses printed today against zero death crosses.
Sector rotation: Health Care leads, Energy recovers structurally
On the day, Health Care was the only sector to post a meaningful positive move at +0.3%, with Energy flat at +0.1% and Communication Services unchanged. That one-day picture extends cleanly over one and three months: Health Care leads both timeframes at +3.1% over one month and +10.7% over three, with Industrials close behind at +2.2% and +10.0% respectively. Utilities round out the three-month podium at +6.0%. The contrast with Energy is notable — it is the worst-performing sector over three months at -10.6%, yet it is also where the Stage-2 advancing cohort is expanding fastest right now, followed by Health Care and then Materials. Financials remain the other three-month laggard at -6.5%.
Standout movers and what cleared the screen today
The day's highest-volume movers came from across the market. Indoco Remedies Ltd (Health Care) rose 18.6% on volume nearly 79 times its average, while PPAP Automotive Ltd (Consumer Discretionary) gained 19% on volume 63.7 times normal — both flagged purely as screening observations on unusual activity. Supreme Infrastructure India Ltd (Industrials) added 10.4% on 28.6 times average volume. Among today's fresh breakouts, Hitech Corporation Ltd (Materials, setup score 8.7) and Nibe Ltd (Industrials, setup score 8.0) cleared the screen with the cleanest base readings; Hester Biosciences Ltd (Health Care, 7.0) adds a Health Care name to the breakout list on a day the sector led. On the sustained-setup side, Thangamayil Jewellery Ltd carries the highest score in the screener at 9.8, with Venus Remedies Ltd (Health Care, 9.6) and Stylam Industries Ltd (Industrials, 9.4) also holding near the top. The five-day transition count of 80 stocks moving from Stage 1 to Stage 2 against only 8 moving from Stage 2 to Stage 3 is the most encouraging internal of the session — a net of 72 names joining the advancing cohort even as the index itself drifted lower.
| Stock | Sector | Setup | % 1D |
|---|---|---|---|
| Hitech Corporation Ltd | Materials | 8.7 | -1.2% |
| Nibe Ltd | Industrials | 8.0 | -4.5% |
| Hester Biosciences Ltd | Health Care | 7.0 | +1.1% |
| Bluspring Enterprises Ltd | Industrials | 6.8 | -2.7% |
| Exicom Tele-Systems Ltd | Information Technology | 6.2 | -9.2% |
| Munjal Auto Industries Ltd | Consumer Discretionary | 5.9 | -3.0% |
| Gloster Ltd | Consumer Discretionary | 5.6 | -1.8% |
| Mankind Pharma Ltd | Health Care | 5.1 | -0.1% |
| Sector | 1D | 1M | 3M | RS | Stage 2 |
|---|---|---|---|---|---|
| Health Care | +0.3% | +3.1% | +10.7% | 74 | 37% |
| Energy | +0.1% | -6.4% | -10.6% | 60 | 46% |
| Communication Services | -0.0% | +3.0% | +5.3% | 63 | 11% |
| Financials | -0.6% | -3.0% | -6.5% | 59 | 24% |
| Real Estate | -0.6% | -2.6% | +0.8% | 38 | 11% |
| Consumer Discretionary | -0.6% | -1.1% | +0.1% | 66 | 22% |
| Materials | -0.7% | -1.4% | +4.7% | 71 | 29% |
| Consumer Staples | -0.8% | -3.3% | +0.4% | 56 | 32% |
| Industrials | -1.3% | +2.2% | +10.0% | 67 | 27% |
| Utilities | -1.4% | +1.0% | +6.0% | 65 | 28% |
| Information Technology | -1.6% | -1.9% | -4.0% | 38 | 19% |
Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing read. New to the method? Start with the four stages.
Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.